首页/数据集/COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

ChEBI2014-01-01 更新2026-07-21 收录

卵巢癌生物标志物

肿瘤预后预测

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-44104 数据链接链接失效反馈

官方服务：

资源简介：

COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

应用场景：

创建时间：

2014-01-01

肿瘤分子病理学

卵巢癌生物标志物

Relationship between CK2α expression and clinicopathological features of EOC patients.

NIAID Data Ecosystem90

Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian Cancer

卵巢癌生物标志物

甲基化预后分析

Altered DNA methylation of tumor suppressor gene promoters plays a role in human carcinogenesis and DNA methyltransferases (DNMTs) are responsible for it. This study aimed to determine aberrant expres

NIAID Data Ecosystem70

Relevance of HE4 and Lewis y Expression in Ovarian Cancer.

卵巢癌生物标志物

HE4与Lewisy表达

Relevance of HE4 and Lewis y Expression in Ovarian Cancer.

Figshare2015-12-02 更新50

Correlation between clinico-pathological parameters and serum VEGF-A, VEGF-C and CA-125 levels in the ovarian cancer cohort.

卵巢癌生物标志物

临床病理关联分析

Correlation between clinico-pathological parameters and serum VEGF-A, VEGF-C and CA-125 levels in the ovarian cancer cohort.

NIAID Data Ecosystem80

Additional file 9 of Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer

卵巢癌生物标志物

细胞焦亡与免疫治疗

Additional file 9: Table S1. Basic characteristics of datasets enrolled in this study for identifying pyroptosis-associated genes (PYAGs) signatures. Table S2. Demographic and clinical characteristics

Figshare2024-02-07 更新60

COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

资源简介：

相关数据集